Breast Cancer, Treatment Reduces Hot Flushes Associated with Endocrine Therapy
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.6 Articles
6 Articles
For women with breast cancer with positive hormonal receptors, a new non-hormonal drug is available to counter hot flushes, one of the side effects that can have a strong impact on the quality of life of women with cancer undergoing endocrine therapy. It is elinzanetant that acts on the mechanisms that regulate the body temperature, explains Matteo Lambertini, director of the Medical Oncology of the Galliera Hospital of Genoa and professor assoc…
(Adnkronos) • The hot flashes that particularly afflict patients with breast cancer who are taking anti-hormonal therapy can be addressed with the new non-hormonal elinzanetant therapy. Important confirmations of its effectiveness come from the annual congress of the European society for medical oncology (Esmo) of Madrid. At the Spanish meeting was presented a post-... Continue reading The article Breast cancer, treatment reduces the hot flashes…
Rec News | Lontani dal mainstream
(Adnkronos) • The hot flashes that particularly afflict patients with breast cancer who are taking anti-hormonal therapy can be addressed with the new non-hormonal elinzanetant therapy. Important confirmations of its effectiveness come from the annual congress of the European society for medical oncology (Esmo) in Madrid. At the Spanish meeting was presented a post- [...] The article Breast cancer, treatment reduces the hot flashes associated wi…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
